Ignite Creation Date:
2025-12-24 @ 9:57 PM
Ignite Modification Date:
2025-12-25 @ 7:35 PM
Study NCT ID:
NCT02128932
Status:
COMPLETED
Last Update Posted:
2019-06-13
First Post:
2014-04-24
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Efficacy and Safety of Semaglutide Once Weekly Versus Insulin Glargine Once Daily as add-on to Metformin With or Without Sulphonylurea in Insulin-naïve Subjects With Type 2 Diabetes
Sponsor:
Novo Nordisk A/S
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-08-04
Start Date Type:
ACTUAL
Primary Completion Date:
2015-09-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-09-03
Completion Date Type:
ACTUAL
First Submit Date:
2014-04-24
First Submit QC Date:
None
Study First Post Date:
2014-05-01
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-12-14
Results First Submit QC Date:
None
Results First Post Date:
2018-03-08
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2016-08-19
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2019-05-28
Last Update Post Date:
2019-06-13
Last Update Post Date Type:
ACTUAL